Lung cancer represents the second most common malignancy worldwide and lymph node (LN) involvement serves as a crucial prognostic factor for tailoring treatment approaches. Invasive methods, such as mediastinoscopy and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), are employed for preoperative LN staging. Among the preoperative non-invasive diagnostic methods, computed tomography (CT) and, recently, positron emission tomography (PET)/CT with fluorine-18-fludeoxyglucose ([F-18]FDG) are routinely recommended by several guidelines; however, they can both miss pathologically proven LN metastases, with an incidence up to 26% for patients staged with [F-18]FDG PET/CT. These undetected metastases, known as occult LN...
Background: Determining the stage of non-small-cell lung cancer often requires multiple preoperative...
Recent studies have shown limitations of morphological imaging in staging mediastinal lymph node inv...
<div><p>Background</p><p>Lymph node stage prior to treatment is strongly related to disease progress...
Background Lymph node stage prior to treatment is strongly related to disease progression and poor p...
Background Lymph node stage prior to treatment is strongly related to disease progression and poor p...
Contains fulltext : 191294.pdf (publisher's version ) (Open Access)BACKGROUND: Lym...
Exact localisation of thoracic lymph nodes (LNs) on fluorine-18 fluoro-2-deoxy-d-glucose positron em...
A portion of gastric cancer patients with negative lymph node metastasis at an early stage eventuall...
Background: Lymph node staging is a critical prognostic factor in non-small cell lung cancer (NSCLC)...
positron emission tomography (FDG-PET) blinded to CT, and FDG-PET visually correlated with CT, in th...
Lymph node stage prior to treatment is strongly related to disease progression and poor prognosis in...
Objectives : We evaluate whether integrated fluorodeoxyglucose-positron emission tomography and comp...
Study objective: To compare the performance of CT, radio-labeled F-18-fluoro-2-deoxy-D-glucose posit...
Objective: Advances in diagnostic imaging techniques, such as 18F-fluorodeoxyglucose positron emissi...
OBJECTIVES: To evaluate the clinical implications of lymph node (LN) density on 18F-FDG PET/CT for m...
Background: Determining the stage of non-small-cell lung cancer often requires multiple preoperative...
Recent studies have shown limitations of morphological imaging in staging mediastinal lymph node inv...
<div><p>Background</p><p>Lymph node stage prior to treatment is strongly related to disease progress...
Background Lymph node stage prior to treatment is strongly related to disease progression and poor p...
Background Lymph node stage prior to treatment is strongly related to disease progression and poor p...
Contains fulltext : 191294.pdf (publisher's version ) (Open Access)BACKGROUND: Lym...
Exact localisation of thoracic lymph nodes (LNs) on fluorine-18 fluoro-2-deoxy-d-glucose positron em...
A portion of gastric cancer patients with negative lymph node metastasis at an early stage eventuall...
Background: Lymph node staging is a critical prognostic factor in non-small cell lung cancer (NSCLC)...
positron emission tomography (FDG-PET) blinded to CT, and FDG-PET visually correlated with CT, in th...
Lymph node stage prior to treatment is strongly related to disease progression and poor prognosis in...
Objectives : We evaluate whether integrated fluorodeoxyglucose-positron emission tomography and comp...
Study objective: To compare the performance of CT, radio-labeled F-18-fluoro-2-deoxy-D-glucose posit...
Objective: Advances in diagnostic imaging techniques, such as 18F-fluorodeoxyglucose positron emissi...
OBJECTIVES: To evaluate the clinical implications of lymph node (LN) density on 18F-FDG PET/CT for m...
Background: Determining the stage of non-small-cell lung cancer often requires multiple preoperative...
Recent studies have shown limitations of morphological imaging in staging mediastinal lymph node inv...
<div><p>Background</p><p>Lymph node stage prior to treatment is strongly related to disease progress...